Showing results (521-530 of 538) with videos related to
Sort By:
Pageof 54
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 6, 2018
Network Architecture Underlying Basal Autonomic Outflow: Evidence from Frontotemporal DementiaVirginia E Sturm, Jesse A Brown, Alice Y Hua, et al.Drug and Alcohol Dependence|December 3, 2021
Alcohol use in emerging adults associated with lower rich-club connectivity and greater connectome network disorganizationJessica P Y Hua, Siemon C de Lange, Martijn P van den Heuvel, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|February 22, 2008
Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trialJess T Whitson, John D Roarty, Lingam Vijaya, et al.Scientific Reports|September 15, 2015
High e+/e- Ratio Dense Pair Creation with 10(21)W.cm(-2) Laser Irradiating Solid TargetsE Liang, T Clarke, A Henderson, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Dominant hemisphere lateralization of cortical parasympathetic control as revealed by frontotemporal dementiaChristine C Guo, Virginia E Sturm, Juan Zhou, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2025
[A multicenter retrospective clinical study of a simplified comprehensive geriatric assessment system in elderly patients with diffuse large B-cell lymphoma]J Y Leng, Y H Cai, X P Ge, et al.The New England Journal of Medicine|September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative ColitisWilliam J Sandborn, Brian G Feagan, Geert D'Haens, et al.The Review of Scientific Instruments|June 2, 2014
Development of the scintillator-based probe for fast-ion losses in the HL-2A tokamakY P Zhang, Yi Liu, X B Luo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximabLuis Fayad, Fritz Offner, Mitchell R Smith, et al.Nature Biotechnology|October 29, 2021
RNA-responsive elements for eukaryotic translational controlEvan M Zhao, Angelo S Mao, Helena de Puig, et al.Pageof 54